Nuzenio

Seres Therapeutics Reports

Seres Therapeutics Reports news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 7 latest news signals 5 publisher sources 100/100 entity strength

Latest news

Seres Therapeutics, Inc. 2Q 2026: Revenue $0.736M, Net income $4.581M, EPS $0.47— 10-Q Summary - TradingViewTradingView · Wed, 05 Aug 2026 14:41:21 GMTSeres Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary - TradingViewTradingView · Wed, 05 Aug 2026 13:13:24 GMTSeres Therapeutics Q2 Net Income Reaches $4.6 Million - Quiver QuantitativeQuiver Quantitative · Wed, 05 Aug 2026 11:16:00 GMTSeres Therapeutics reports Q2 2026 net income of $4.6M, cash $15.6M, advances SER-155 clinical plans - TradingViewTradingView · Wed, 05 Aug 2026 11:13:00 GMTSeres Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Updates, Including Further Action to Reduce Ongoing Facilities Costs - Yahoo! Finance CanadaYahoo! Finance Canada · Wed, 05 Aug 2026 11:00:00 GMTSeres Reports 80% Response in Colitis Linked to Cancer Therapy - Stock TitanStock Titan · Wed, 05 Aug 2026 11:00:00 GMTSeres Therapeutics reports positive trial resul... - PluangPluang · Wed, 05 Aug 2026 07:00:00 GMT

Timeline

Wed, 05 Aug 2026 14:41:21 GMTSeres Therapeutics, Inc. 2Q 2026: Revenue $0.736M, Net income $4.581M, EPS $0.47— 10-Q Summary - TradingView
Wed, 05 Aug 2026 13:13:24 GMTSeres Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary - TradingView
Wed, 05 Aug 2026 11:16:00 GMTSeres Therapeutics Q2 Net Income Reaches $4.6 Million - Quiver Quantitative
Wed, 05 Aug 2026 11:13:00 GMTSeres Therapeutics reports Q2 2026 net income of $4.6M, cash $15.6M, advances SER-155 clinical plans - TradingView
Wed, 05 Aug 2026 11:00:00 GMTSeres Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Updates, Including Further Action to Reduce Ongoing Facilities Costs - Yahoo! Finance Canada
Wed, 05 Aug 2026 11:00:00 GMTSeres Reports 80% Response in Colitis Linked to Cancer Therapy - Stock Titan

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Seres Therapeutics Reports.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

5 distinct publisher/source names are currently connected to this entity page.